These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15907584)

  • 1. A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles.
    Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
    J Control Release; 2005 May; 104(2):337-46. PubMed ID: 15907584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats.
    Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
    J Pharmacol Exp Ther; 2005 Oct; 315(1):196-202. PubMed ID: 15980057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery.
    Meissner Y; Pellequer Y; Lamprecht A
    Int J Pharm; 2006 Jun; 316(1-2):138-43. PubMed ID: 16675176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
    Lamprecht A; Ubrich N; Yamamoto H; Schäfer U; Takeuchi H; Maincent P; Kawashima Y; Lehr CM
    J Pharmacol Exp Ther; 2001 Nov; 299(2):775-81. PubMed ID: 11602694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial heparin delivery via microspheres mitigates experimental colitis in mice.
    Pellequer Y; Meissner Y; Ubrich N; Lamprecht A
    J Pharmacol Exp Ther; 2007 May; 321(2):726-33. PubMed ID: 17322027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.
    Pertuit D; Moulari B; Betz T; Nadaradjane A; Neumann D; Ismaïli L; Refouvelet B; Pellequer Y; Lamprecht A
    J Control Release; 2007 Nov; 123(3):211-8. PubMed ID: 17889397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of pH-sensitive microspheres for the colonic delivery of the immunosuppressive drug tacrolimus.
    Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
    Eur J Pharm Biopharm; 2004 Jul; 58(1):37-43. PubMed ID: 15207535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK506 microparticles mitigate experimental colitis with minor renal calcineurin suppression.
    Lamprecht A; Yamamoto H; Ubrich N; Takeuchi H; Maincent P; Kawashima Y
    Pharm Res; 2005 Feb; 22(2):193-9. PubMed ID: 15783066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis.
    Moulari B; Pertuit D; Pellequer Y; Lamprecht A
    Biomaterials; 2008 Dec; 29(34):4554-60. PubMed ID: 18790531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colonic delivery of carboxyfluorescein by pH-sensitive microspheres in experimental colitis.
    Kietzmann D; Moulari B; Béduneau A; Pellequer Y; Lamprecht A
    Eur J Pharm Biopharm; 2010 Oct; 76(2):290-5. PubMed ID: 20600885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis.
    Pharmacology; ; . PubMed ID: 31940656
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.